Concise Review: Expanding Roles for Hematopoietic Cellular Therapy and the Blood Transfusion Services

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Stem Cells

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/stem.689PMID 21739527
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesenchymal stem cells in ex vivo cord blood expansion.

  2011cited by this paper
• Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells

  2010cited by this paper
• Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution

  2010cited by this paper
• Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine

  2010cited by this paper
• Human T regulatory cell therapy: take a billion or so and call me in the morning.

  2009cited by this paper
• New cellular therapies: Is there a role for transfusion services?

  2009cited by this paper
• Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.

  2009cited by this paper
• Biologic properties and enucleation of red blood cells from human embryonic stem cells.

  2008cited by this paper
• Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor.

  2008cited by this paper
• Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.

  2008cited by this paper
• The role of blood services and regulatory bodies in stem cell transplantation

  2007cited by this paper
• Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche

  2007cited by this paper
• Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells

  2006cited by this paper
• Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

  2006cited by this paper
• Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue

  2006cited by this paper
• Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

  2006cited by this paper
• Regulatory T cells in transplantation tolerance.

  2005cited by this paper
• Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers

  2005cited by this paper
• Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab

  2005cited by this paper
• Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.

  2004cited by this paper
• Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays

  2004cited by this paper
• Male DNA in female donor apheresis and CD34-enriched products.

  2003cited by this paper
• Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

  2003cited by this paper
• Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

  2002cited by this paper
• Rare Blood Donors: The Past and the Future

  2002cited by this paper
• Tracking the Immunoregulatory Mechanisms Active During Allograft Tolerance1

  2002cited by this paper
• The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

  2002cited by this paper
• Microchimerism, GVHD, and tolerance in solid organ transplantation

  2001cited by this paper
• Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region-derived stromal cells.

  2001cited by this paper
• The end of the beginning for pluripotent stem cells

  2001cited by this paper
• Human Marrow-Derived Mesenchymal Stem Cells (MSCs) Express Hematopoietic Cytokines and Support Long-Term Hematopoiesis When Differentiated Toward Stromal and Osteogenic Lineages

  2000cited by this paper
• Leucocyte Depletion Of The Blood Supply – How Will Patients Benefit?

  2000cited by this paper
• Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy.

  2000cited by this paper
• Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients.

  1999cited by this paper
• Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

  1999cited by this paper
• Evaluation of seven PCR-based assays for the analysis of microchimerism.

  1998cited by this paper
• Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis.

  1998cited by this paper
• Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells.

  1997cited by this paper
• CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens

  1997cited by this paper
• High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing.

  1997cited by this paper
• Differential Maintenance of Primitive Human SCID-Repopulating Cells, Clonogenic Progenitors, and Long-Term Culture-Initiating Cells After Incubation on Human Bone Marrow Stromal Cells

  1997cited by this paper
• CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies.

  1996cited by this paper
• Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.

  1996cited by this paper
• Ex vivo expansion of hematopoietic stem and progenitor cells--robbing Peter to pay Paul? [editorial]

  1993cited by this paper
• Ex vivo expansion of hematopoietic stem and progenitor cells--robbing Peter to pay Paul?

  1993cited by this paper
• Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage.

  1992cited by this paper
• Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action

  1990cited by this paper
• Cytomegalovirus infections after allogeneic bone marrow transplantation.

  1990cited by this paper

• Magnetic Delivery of Cell-Based Therapies

  2018cites this paper
• Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations

  2015cites this paper
• [Blood transfusion and paradoxes].

  2015cites this paper
• Feasibility study of red blood cell debulking by magnetic field-flow fractionation with step-programmed flow

  2014cites this paper
• Regional localization within the bone marrow influences the functional capacity of human HSCs.

  2013cites this paper
• Stem Cells and Cloning : Advances and Applications Age-old wisdom concerning cell-based therapies with added knowledge in the stem cell era : our perspectives

  2013cites this paper
• 2012 and beyond

  2012cites this paper